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Obesity is defined as the excess adipose tissue in the body. Drugs responsible for inhibiting the appetite 
are called anorectics or appetite suppressants. Sibutramine, fenproporex and amfepramone belongs to 
this class, and are capable of causing physical or psychological dependence. The aim of this study was 
to evaluate the frequency of prescriptions for appetite suppressants in community pharmacies at Cruz 
Alta, State of Rio Grande do Sul, Brazil. The sales of fenproporex, amfepramone and sibutramine in the 
months of September, October and November 2010 and April, May and June 2011 were compared. It 
was observed that the most commonly dispensed anorectic in the three community pharmacies analyzed 
was sibutramine. In the months of September, October and November 2010, consumption was higher, 
with sibutramine achieving 40.3% of overall sales, amfepramone 21% and, finally, fenproporex, 7.9%. 
The consumption of appetite suppressants was more prevalent in females, who represented 82% of total. 
The results suggested the existence of high consumption of anorectics, possibly related to the current 
concern with aesthetic standards, which emphasizes the importance of strict control over the marketing 
of these substances.
Uniterms: Drugs/prescriptions. Drugs/marketing control. Obesity/treatment. Anorectics. Amphetamine.
Obesidade define-se como excesso de tecido adiposo no organismo. Os fármacos responsáveis por 
inibir o apetite são denominados anorexígenos ou supressores de apetite. Sibutramina, femproporex 
e anfepramona, pertencentes a essa classe, são capazes de provocar dependência física ou psíquica. O 
objetivo deste estudo foi avaliar a prevalência da prescrição de anorexígenos em farmácias comerciais 
de Cruz Alta – RS. Foi comparada a venda dos fármacos femproporex, anfepramona e sibutramina, 
nos meses de setembro, outubro e novembro de 2010 e abril, maio e junho de 2011. Observou-se que 
o anorexígeno mais prescrito nas três farmácias analisadas foi a sibutramina. Nos meses de setembro, 
outubro e novembro de 2010, o consumo foi maior, quando a sibutramina alcançou um percentual de 
40,3%, a anfepramona 21% e, por fim, o femproporex, 7,9%. O consumo de inibidores de apetite foi 
mais prevalente no sexo feminino, o qual representou 82% do total. Os resultados sugeriram a existência 
de elevado consumo de anorexígenos, possivelmente relacionada à preocupação com padrões estéticos 
atuais, o que ressalta a importância de um controle rigoroso sobre a comercialização destas substâncias.
Unitermos: Fármacos/prescrição. Fármacos/controle comercial. Obesidade/tratamento. Anorexígenos. 
Anfetamina.
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INTRODUCTION
Obesity is a public health problem that affects 
millions of people and has a complex treatment that 
involves modifying dietary habits through reeducation. 
It also covers caloric restriction, physical activity, and 
behavioral changes (Almeida, Polese, Ribeiro, 2000; 
Mancini, 2002).
For a long time, the treatment of obesity was an 
option subject to much criticism due to the irrational 
use of available drugs and the abuse of drugs sold by 
compounding pharmacies. The process is undergoing 
a revaluation, showing that obese individuals must 
accomplish appropriate steps to weight loss, under medical 
supervision (Gray et al., 2012).
Self-medication can be defined as a situation when a 
person has the initiative of consuming a medicine without 
professional guidance. This behavior can be observed 
among obese people, and also among individuals with 
aesthetic motivations who do not have this morbidity 
(Paulo, Zanini, 1998).
A large portion of appetite suppressants (also known 
as anorectics) is based on amphetamines, which were 
synthesized to combat obesity and depression, in early 
1920s. Later, their use became popular among young 
people to reduce sleepiness and gain a better body shape. 
However, their major therapeutic indication remains the 
treatment of obesity, becoming part of most formulations 
for appetite reduction (Murer, 2007). They stimulate the 
central nervous system and suppress appetite, and can also 
cause amphetamine syndrome, which is characterized by 
euphoria, decreased fatigue, and increased intellectual 
capacity (Silva, 1998).
Fenproporex and amfepramone are amphetamine 
derivatives widely used as anorectics, for assisting in the 
treatment of obesity. Even being known as substances with 
high potential for abuse and dependence, they are among 
the most prescribed drugs in Brazil. The indiscriminate 
use of appetite suppressants may pose a risk to their users, 
since these drugs can have serious side effects. Thus, this 
study aims to estimate the frequency of use of appetite 
suppressants such as fenproporex, amfepramone and 
sibutramine.
MATERIAL AND METHODS
Data were obtained from the database of three 
randomly selected commercial community pharmacies 
from the city of Cruz Alta, in the northwestern region 
of Rio Grande do Sul State, Brazil. Each establishment 
was located in the city downtown. In this cross-
sectional observational study, we analyzed the frequency 
of dispensations of three anorectics: fenproporex, 
sibutramine, and amfepramone. Data were obtained 
from the National System of Controlled Product 
Management (SNGPC), a database that allows to control 
the consumption of controlled drugs in each pharmacy. We 
analyzed the frequency of dispensations from the months 
of September, October and November 2010 and April, 
May and June 2011.
Data tabulation was performed using Microsoft® 
Excel® 2010 software. The frequency of the prescription of 
the selected drugs was determined by gender and according 
to the season: September, October and November (spring 
time) and April, May and June (autumn time).
RESULTS AND DISCUSSION
This study analyzed a total of 315 prescriptions. 
It was found that the most sold anorectic drug in the 
three commercial pharmacies was sibutramine, with 170 
prescriptions (representing 54% of total sales), followed 
by amfepramone, with 104 (33%) and fenproporex, with 
41 (13%). Literature regarding the level of dispensation 
of these drugs among the general population is scarce. 
Differently from what we found, a study by Nadja et 
al. (2010), observed that the most consumed of these 
drugs was fenproporex, followed by amfepramone and 
sibutramine. Another study, reported that amphetamine 
substances are highly used among nursing students, and 
that most of them began to use these substances when 
they started academic life. The use of anorectics was 
justified by the stress generated by the new routine and 
by the amount of activities performed at the university 
(Mardegan et al., 2007). Noto et al. (2002) found 
that compounding pharmacies are a major source of 
dispensation of anorectic drugs, the most prescribed of 
which were amfepramone and fenproporex. Bejola et al. 
(2009) evaluated medical prescriptions and showed that, 
in 50% of cases, appetite suppressants are prescribed as 
monotherapy, and that the most prescribed drugs were 
fenproporex (26%), followed by amfepramone (12%) and 
sibutramine (11%). The data found in our study are not in 
agreement with the available literature, which allows to 
infer that our results may have been influenced by specific 
factors related to prescription, e.g., clinician preferences 
or adoption of specific therapeutic regimens. The fact of 
literature pointing out that community pharmacies can also 
be sources of acquisition of these drugs for non-therapeutic 
purposes is enough to suggest more studies on the topic.
Figure 1 shows the analysis of 315 prescription 
notifications, revealing that there is a difference in 
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(Mardegan et al., 2007). Noto et al. (2002) found 
that compounding pharmacies are a major source of 
dispensation of anorectic drugs, the most prescribed of 
which were amfepramone and fenproporex. Bejola et al. 
(2009) evaluated medical prescriptions and showed that, 
in 50% of cases, appetite suppressants are prescribed as 
monotherapy, and that the most prescribed drugs were 
fenproporex (26%), followed by amfepramone (12%) and 
sibutramine (11%). The data found in our study are not in 
agreement with the available literature, which allows to 
infer that our results may have been influenced by specific 
factors related to prescription, e.g., clinician preferences 
or adoption of specific therapeutic regimens. The fact of 
literature pointing out that community pharmacies can also 
be sources of acquisition of these drugs for non-therapeutic 
purposes is enough to suggest more studies on the topic.
Figure 1 shows the analysis of 315 prescription 
notifications, revealing that there is a difference in 
consumption of anorectic drugs in different seasons. The 
consumption of the three drugs was much more higher in 
the months of September, October and November 2010, 
with sibutramine achieving a total of 127 prescriptions 
(40.3%), followed by amfepramone, with 66 (21%) and 
fenproporex, with 25 (7.9%). In the months of April, May 
and June 2011, there were 43 (13.6%) prescriptions of 
sibutramine, 38 (12.1%) of amfepramone, and 16 (5.1%) 
of fenproporex. These results are similar to those found 
in the literature. An investigation by Feltrin et al. (2009) 
comparing the consumption of anorectics between the 
months of September 2006 and February 2007 found that 
the largest amounts of drugs were dispensed in November 
2006 (17.67%), followed by October 2006 (17.67%), 
December 2006 (17.32%), January 2007 (15.71%), 
September 2006 (14.80%) and, finally, February 2007 
(13.81%), which had the lowest rate of sales. These results 
suggest that the demand for anorectic drugs increases with 
proximity to summer in Brazil, possibly due to a greater 
concern with appearance and increased exposure of the 
body at this time of year (Silva, 2002). Generally, these 
drugs are used by individuals who are concerned only to 
reducing weight gained during the winter season and who 
do not have the profile required for this type of treatment 
(Feltrin et al., 2009).
Data shown in figure 2 demonstrate that the 
percentages of consumption remained virtually identical 
among men and women in both periods, being higher 
among women, who were responsible for ordering 
122 (81.8%) prescriptions in the months of September, 
October and November 2010 (approaching summer) and 
67 prescriptions (81.7%) in the months of April, May and 
June 2011 (next to winter), when exposure of the body is 
minimum. In male patients, there was less consumption, 
which accounted for 27 (18.2%) prescriptions in the months 
of September, October and November 2010 and 15 (18.3%) 
prescriptions in the months of April, May and June 2011.
FIGURE 1 - Percentage of each drug dispensed by months 
September to November 2010 and April to June 2011.
FIGURE 2 - Consumption of anorectics: gender/season relation.
FIGURE 3 - Anorectics dispensation frequency in community 
pharmacies A, B e C.
It  can be observed that the use of appetite 
suppressants was more prevalent in females. These values 
are in agreement with those found in the study by Feltrin et 
al. (2009), who showed that 93.35% of users of anorectic 
drugs were females and only 6.65% were males. Another 
study consistent with the data in Figure 3 was performed 
by Bejola et al. (2009), who found that females accounted 
for 80% of total consumption of anorectic drugs, while 
men accounted for 20%. These results suggest that the 
use of this type of substance between women is probably 
related to aesthetical motivations (Lopes et al., 1997). This 
probable concern with aesthetics is reinforced considering 
that consumption was higher in warmer months among 
both sexes, despite being markedly higher in females than 
in males.
According to Figure 3, we observed that the 
dispensation of sibutramine was higher in pharmacy 
B, representing 87 (51.2%) dispensations, followed by 
pharmacy C, with 44 (25.8%), and pharmacy A, with 39 
(23%). The largest amount of amfepramone was dispensed 
in pharmacy B, with 56 (53.8%) dispensations, followed 
by pharmacy C, with 36 (34.6%), and pharmacy A, 
with 12 (11.6%). Fenproporex showed a higher level of 
dispensation in pharmacy A, where they accounted for 17 
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(11.6%) dispensations, followed by pharmacy B, with 14 
(34.1%), and pharmacy C, with 10 (24.4%). According 
to a study conducted in community pharmacies at Belo 
Horizonte, Brazil, the pharmacy that stood first in sales 
of psychotropic anorectics accounted for 39.8% of all 
notifications. Some reasons for higher frequencies of 
dispensations could be the quality offered in price policy 
and services, as well as marketing strategies (Carneiro, 
Guerra Jr, Acurcio, 2008).
CONCLUSION
The findings in this study suggest that consumption 
of anorectics in the population studied is possibly linked to 
aesthetic motivations, whose current standards primarily 
affect women. Consumption was greater in the warmer 
months approaching summer, i.e., September, October 
and November, when the most prescribed drug was 
sibutramine. This is the time when people have greater 
physical exposure and are more concerned about staying 
within an aesthetically ideal low weight. Considering 
aesthetics as a possible motivation for these findings, 
drug treatment is not considered the best option for a 
faster weight loss. Also, considering the implication of 
these drugs with possible damage to the health as a result 
of misuse, further studies are suggested to evaluate the 
reasons that motivated the consumption of anorectics 
among the population studied, a topic that was not 
evaluated in this work.
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